Preparation of buffy coat platelet hyperconcentrates treated with Mirasol® Pathogen Reduction Technology and stored in PAS

被引：0
|
作者：
de Korte, Dirk [1 ]
Marschner, S. [2 ]
Gouwerok, E. [3 ]
Vlaar, R.
Goodrich, R. [4 ]
机构：
[1] Sanquin Blood Bank Reg N W, Amsterdam, Netherlands
[2] Navigant Biotechnol, Lakewood, CO USA
[3] Sanquin Res, Amsterdam, Netherlands
[4] Navigant Biotechnol LLC, Lakewood, CO USA
来源：
TRANSFUSION | 2008年 / 48卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：154A / 154A
页数：1
相关论文
共 50 条
  • [21] Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis
    Janetzko, Karin
    Hinz, Katharina
    Marschner, Susanne
    Goodrich, Ray
    Klueter, Harald
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2009, 36 (05) : 309 - 315
  • [22] EFFECT OF MIRASOL PATHOGEN REDUCTION TECHNOLOGY SYSTEM ON QUALITY OF PLATELETS STORED IN PLASMA
    Llohn, A.
    Skogheim, R.
    Flesland, A.
    Oedegaard, E.
    Mastroianni, M.
    Nybruket, M.
    Nentwich, I
    VOX SANGUINIS, 2011, 101 : 77 - 77
  • [23] BUFFY COAT DERIVED PLATELET CONCENTRATES STORED IN PLASMA, PLASMA-LYTE-A AND PAS-II
    HAWKER, RJ
    MITCHELL, SG
    TURNER, VS
    TRANSFUSION, 1995, 35 (10) : S36 - S36
  • [24] Evaluation of the quality of Apheresis platelets treated with Mirasol® pathogen reduction technology
    Eakins, E.
    Murphy, C.
    Croxon, H.
    Birhire, R.
    Flynn, N.
    Taylor, S.
    Murphy, W.
    TRANSFUSION, 2008, 48 (02) : 21A - 21A
  • [25] EVALUATION OF CYTOKINE ACCUMULATION IN MIRASOL® PATHOGEN REDUCTION TECHNOLOGY TREATED PLATELETS
    Castrillo, A.
    Abad, M. L.
    Arcas, C.
    Costoya, S.
    Rodriguez, M., I
    VOX SANGUINIS, 2010, 99 : 250 - 251
  • [26] The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover
    Johnson, L.
    Winter, K. M.
    Reid, S.
    Hartkopf-Theis, T.
    Marschner, S.
    Goodrich, R. P.
    Marks, D. C.
    VOX SANGUINIS, 2011, 101 (03) : 208 - 214
  • [27] Platelet Recovery and Survival After Whole Blood Treated with Mirasol Pathogen Reduction
    Hervig, T. A.
    Braathen, H.
    Jaboori, A. A.
    Deberdt, L.
    Bailey, L. S.
    Lunde, T. F.
    TRANSFUSION, 2016, 56 : 194A - 194A
  • [28] In Vivo Recovery of Platelets Treated with Pathogen Reduction Technology Stored in Platelet Additive Solutions
    Drawz, S. M.
    Marschner, S.
    Yanez, M.
    Garcia de Coca, A.
    Coene, J.
    TRANSFUSION, 2014, 54 : 40A - 41A
  • [29] Neutrophil Priming Activity in Platelet Concentrates (PCs) Collected by Apheresis and Treated with Mirasol® Pathogen Reduction Technology (PRT)
    Ambruso, D. R.
    Thurman, G.
    Tran, K.
    Marschner, S.
    Goodrich, R. P.
    TRANSFUSION, 2009, 49 : 9A - 9A
  • [30] Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology
    Li, JZ
    Lockerbie, O
    de Korte, D
    Rice, J
    McLean, R
    Goodrich, RP
    TRANSFUSION, 2005, 45 (06) : 920 - 926
12345